Concepedia

Katarina Luptakova

KL

20

Publications

1.3K

Citations

15

H-Index

2010

Active since

Affiliations

Dana-Farber Cancer Institute(Current)

Beth Israel Deaconess Medical Center

Harvard University

Millennium Engineering and Integration (United States)

Medical College of Wisconsin

Katarina Luptakova is an author at Dana-Farber Cancer Institute specializing in medicine, oncology, and immunotherapy.

ORCID

Top concepts

Publications per year

2010–2020

20

Publications

20

Niraparib monotherapy for late-line treatment of ovarian cancer (QUADRA): a multicentre, open-label, single-arm, phase 2 trial

Kathleen N. Moore, Angeles Alvarez Secord, Melissa A. Geller et al. · The Lancet Oncology · 2019 · 516 citations

, , +6

Individualized vaccination of AML patients in remission is associated with induction of antileukemia immunity and prolonged remissions

Jacalyn Rosenblatt, Richard M. Stone, Lynne Uhl et al. · Science Translational Medicine · 2016 · 162 citations · Full text

Lenalidomide enhances anti-myeloma cellular immunity

Katarina Luptakova, Jacalyn Rosenblatt, Brett Glotzbecker et al. · Cancer Immunology Immunotherapy · 2012 · 157 citations · Full text

, , +6

Apoptosis induced by JAK2 inhibition is mediated by Bim and enhanced by the BH3 mimetic ABT-737 in JAK2 mutant human erythroid cells

Britta Will, Tanya Siddiqi, Meritxell Alberich-Jordà et al. · Blood · 2010 · 52 citations · Full text

MUC1 Is a Potential Target for the Treatment of Acute Myeloid Leukemia Stem Cells

Dina Stroopinsky, Jacalyn Rosenblatt, Keisuke Ito et al. · Cancer Research · 2013 · 52 citations · Full text

Rows per page

1–5 of 20